HPV and host factors in juvenile onset recurrent respiratory papillomatosis
- Institution
- CINCINNATI CHILDRENS HOSP MED CTR, OH
- Principal investigator
- Susanne I Wells
- Funding
- $447K
- Duration
- 2024–2029
Moonbase score
Still being scored
Abstract
ABSTRACT. Patients with juvenile-onset recurrent respiratory papillomatosis (JoRRP) suffer from recurring epithelial papillomas along the respiratory tract caused by low-risk H PV viruses, predominantly H PV6. This most common benign neoplasm in children varies significantly in clinical course. Patients undergo an average of 4-5 surgeries in the first year post-diagnosis, and severe cases can result in hundreds of surgeries and progression to cancer. The lack of effective medications significantly lowers the quality of life for children with RRP, and highlights the need for new biomarkers and therapies. To develop therapeutics and prognostic markers requires overcoming a deep gap in knowledge of viral and host cell factors that produce papillomas (ie, candidate targets and markers). This is now possible thanks to the development of models of normal and JoRRP 3D stratified squamous epithelium (SE). Using fresh tumor and matched nondiseased (ND) tissue from children with JoRRP, we generated primary monolayer keratinocytes, which we then engineered into organotypic epithelial rafts. With this established pipeline of internally controlled 2D/3D models, we have made significant strides. Our global transcriptome analyses of 2D JoRRP/ND keratinocytes defined a JoRRP-specific EMT-like disease signature, which we validated in rafts and patient specimens. Single-cell RNA sequencing (scRNAseq) of HPV6+ RRP specimens (vs matched HPV- ND controls) further uncovered 16 transcriptionally distinct keratinocyte subpopulations (clusters C0-15). CS bears striking similarity to our recently published cancerassociated "HI ODEN" subpopulation induced by high-risk HPV16. Both are located in superficial layers where H PV amplification occurs, and both share biomarkers including the ELF3 transcription factor, which is required for HIDDEN formation. Our new data show that the HPV16 E6/E7 oncogenes are sufficient to induce HI ODEN, suggesting that conserved HPV6 E6/E7 activities might induce analogous subpopulations at the epithelial surface. In Aim1, we test whether and how HPV6 E6 and/or E? induce CS, and whether CS is required for viral progeny production. Our scRNAseq data also revealed striking abundance of HPV6 E5γ and δ transcripts across clusters, indicating importance for viral processes and/or keratinocyte phenotypes. While functions of low-risk HPV E5γ/δ proteins are unstudied in translational disease models, HPV6 E5γ was reported to bind the EGFR and ERBB2 receptor tyrosine kinases. In Aim2, we test whether HPV6 E5γ and/or E5δ sustain JoRRP phenotypes, and whether they do so, at least in part, via EGFR/ERBB2 signaling.
Research team
- David F SmithPI
- Susanne I WellsPI
LOADING MOONBASE SCORE
Questions for CINCINNATI CHILDRENS HOSP MED CTR
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Cincinnati Childrens Hosp Med CtrNot yet scored
Cell-Cell Signaling Driving HPV-Induced Respiratory Disease and Vaccine Response
Susanne I Wells · $95K · 2025–2030
- NIH · Cincinnati Childrens Hosp Med Ctr54
Sirolimus TSC Epilepsy Prevention Study (STEPS) IND#145820 11/8/2019
Martina Bebin · $651K · 2021–2027
- NIH · Cincinnati Childrens Hosp Med Ctr48
Abatacept for the treatment of Common Variable Immunodeficiency with Interstitial Lung Disease (ABCVILD) IND #152820 9/2/20
Michael Jordan · $530K · 2021–2027